This inventor holds 8 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Mei Pharma, Inc., S'bio Pte Ltd. Active years: 2010-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2020
Title: Niefang Yu: Innovator in Pharmaceutical Applications
Introduction
Niefang Yu is a prominent inventor based in Singapore, known for his significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, he has made remarkable strides in developing innovative compounds that have potential therapeutic applications.
Latest Patents
One of Niefang Yu's latest patents focuses on benzimidazole derivatives, specifically their preparation and pharmaceutical applications. This invention relates to hydroxamate compounds that act as inhibitors of histone deacetylase (HDAC). The compounds developed may serve as medicaments for treating proliferative disorders and other diseases associated with the dysregulation of HDAC.
Career Highlights
Throughout his career, Niefang Yu has worked with notable companies such as Mei Pharma, Inc. and S*bio Pte Ltd. His work has been instrumental in advancing the understanding and application of histone deacetylase inhibitors in medical treatments.
Collaborations
Niefang Yu has collaborated with esteemed colleagues, including DiZhong Chen and Eric T Sun, contributing to the advancement of research in his field.
Conclusion
Niefang Yu's innovative work in the pharmaceutical industry highlights his dedication to developing effective treatments for various diseases. His contributions continue to impact the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile